Acumen Pharmaceuticals (ABOS) Stock Chart & Stock Price History $1.50 +0.13 (+9.06%) As of 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acumen Pharmaceuticals Stock Price Performance The Acumen Pharmaceuticals (ABOS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 50.98%, with a year-to-date return of -12.50%. In the past month, the stock has increased 23.36%, reflecting recent market activity. As of the latest close, Acumen Pharmaceuticals traded at $1.38 with a market cap of $83.59 million and volume of 412,186 shares. Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+7.50%1 Month Performance+23.36%3 Month Performance+67.07%Year-To-Date Performance-12.50%1 Year Performance-50.98% ABOS Stock Chart for Thursday, July, 17, 2025 ABOS Chart by TradingView Acumen Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/16/2025$1.31$1.38+5.34%$1.45$1.33412,186 shs$83.59 million07/15/2025$1.49$1.31-12.08%$1.44$1.263.42 million shs$79.35 million07/14/2025$1.40$1.49+6.43%$1.50$1.39539,703 shs$90.25 million07/11/2025$1.30$1.40+7.69%$1.47$1.311.46 million shs$84.80 million07/10/2025$1.25$1.30+4.00%$1.32$1.21361,418 shs$78.74 million07/09/2025$1.21$1.25+3.31%$1.27$1.23204,785 shs$75.71 million07/08/2025$1.16$1.21+4.31%$1.25$1.15377,826 shs$73.29 million07/07/2025$1.17$1.16-0.43%$1.18$1.14162,237 shs$70.27 million07/04/2025$1.17$1.17$1.17$1.1394,007 shs$70.57 million07/03/2025$1.13$1.17+3.10%$1.17$1.1394,007 shs$70.56 million Get the Latest News and Ratings for ABOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/02/2025$1.11$1.13+1.80%$1.16$1.10167,199 shs$68.44 million07/01/2025$1.16$1.11-4.31%$1.17$1.10198,910 shs$67.23 million06/30/2025$1.12$1.16+3.57%$1.18$1.13344,710 shs$70.26 million06/27/2025$1.21$1.12-7.44%$1.22$1.125.67 million shs$67.84 million06/26/2025$1.23$1.21-1.63%$1.26$1.21213,758 shs$73.29 million06/25/2025$1.26$1.23-2.38%$1.26$1.21335,848 shs$74.51 million06/24/2025$1.23$1.26+2.44%$1.28$1.20277,030 shs$76.32 million06/23/2025$1.20$1.23+2.50%$1.26$1.15566,584 shs$74.50 million06/20/2025$1.22$1.20-1.64%$1.22$1.15382,916 shs$72.69 million06/19/2025$1.22$1.22$1.31$1.18531,525 shs$73.90 million06/18/2025$1.22$1.22$1.31$1.18531,525 shs$73.90 million06/17/2025$1.14$1.22+7.02%$1.25$1.15547,122 shs$73.90 million06/16/2025$1.07$1.14+6.54%$1.16$1.05189,123 shs$69.05 million Related Companies OCGN Stock Chart TKNO Stock Chart TRDA Stock Chart CRVS Stock Chart PVLA Stock Chart TSVT Stock Chart TNXP Stock Chart ALLO Stock Chart INZY Stock Chart ALDX Stock Chart Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABOS) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acumen Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acumen Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
